In addition, subgroup analysis for RFS showed that the expression of SLC39A1 was associated with RFS in male patients (P = 0.012) and patients with young age (P = 0.032) and poorly differentiated tumor (P = 0.033) (Figure 4(b)). This evidence concerns the gene SLC39A1 and neoplasm.